Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Platform for Next-generation DNA Sequencing Based Personalized Treatment for Cancer Patients: Protocol to Obtain Biopsies From Patients With Locally Advanced or Metastatic Cancer (CPCT - 02 Biopsy Protocol)

NCT01855477 is registered in ClinicalTrials.gov with Foundation CPCT as lead sponsor.

NCT NCT01855477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01855477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Platform for Next-generation DNA Sequencing Based Personalized Treatment for Cancer Patients: Protocol to Obtain Biopsies From Patients With Locally Advanced or Metastatic Cancer (CPCT - 02 Biopsy Protocol)
Lead sponsor
Foundation CPCT
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2011
Completion date
December 18, 2023
Enrollment
6,927 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic disease, solid tumors